The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review

The opioid epidemic is an ongoing public health crisis, and the United States health system is overwhelmed with increasing numbers of opioid-related overdoses. Methocinnamox (MCAM) is a novel mu opioid receptor antagonist with an extended duration of action. MCAM has potential to reduce the burden o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, Colleen G., Kennalley, Amy L., Roberts, Alivia L., Nemes, Kaitlyn M., Dolma, Tenzing, Piper, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149874/
https://www.ncbi.nlm.nih.gov/pubmed/35645327
http://dx.doi.org/10.3390/pharmacy10030048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149874/
https://www.ncbi.nlm.nih.gov/pubmed/35645327
http://dx.doi.org/10.3390/pharmacy10030048

Ejemplares similares